Leomar Y Ballester, M.D., Ph.D.

Peer-Reviewed Articles

1. Dono A, Zhu P, Holmes E, Takayasu T, Zhu JJ, Blanco AI, Hsu S, Bhattacharjee MB, Ballester LY, Kim DH, Esquenazi Y, Tandon N. Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma. J Neurooncol. e-Pub 2022. PMID: 34997451.
2. Lopez-Garcia CA, Lopez-Rivera V, Dono A, Salazar-Marioni S, Novo JE, Sheth SA, Ballester LY, Esquenazi Y. Hormone exposure and its suppressive effect on risk of high-grade gliomas among patients with breast cancer. J Clin Neurosci 94:200-203, 2021. e-Pub 2021. PMID: 34863438.
3. Otani Y, Sur HP, Rachaiah G, Namagiri S, Chowdhury A, Lewis CT, Shimizu T, Gangaplara A, Wang X, Vézina A, Maric D, Jackson S, Yan Y, Zhengping Z, Ray-Chaudhury A, Kumar S, Ballester LY, Chittiboina P, Yoo JY, Heiss J, Kaur B, Banasavadi-Siddegowda YK. Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma. Neuro Oncol 23(9):1481-1493, 2021. PMID: 33556161.
4. Dono A, Pothiawala AZ, Lewis CT, Bhattacharjee MB, Ballester LY, Tandon N. Molecular Alterations in Meningioangiomatosis Causing Epilepsy. J Neuropathol Exp Neurol. e-Pub 2021. PMID: 34580720.
5. Dono A, Chandra A, Ballester LY Esquenazi Y. Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma. Neurosurgery 89(1):E66-E67, 2021. PMID: 33826714.
6. McCormack RM, Zhu P, Dono A, Takayasu T, Bhatia A, Blanco AI, Tandon N, Ostrom QT, Gonzales A, Moreno S, Ballester LY, Esquenazi Y. Role of Ethnicity and Geographic Location on Glioblastoma IDH1/IDH2 Mutations. World Neurosurg 149:e894-e912, 2021. e-Pub 2021. PMID: 33516867.
7. Dono A, Mitra S, Shah M, Takayasu T, Zhu JJ, Tandon N, Patel CB, Esquenazi Y, Ballester LY. PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma. J Neurooncol 153(1):153-160, 2021. e-Pub 2021. PMID: 33881725.
8. Dono A, Lopez-Rivera V, Chandra A, Lewis CT, Abdelkhaleq R, Sheth SA, Ballester LY, Esquenazi Y. Predictors of outcome in pleomorphic xanthoastrocytoma. Neurooncol Pract 8(2):222-229, 2021. e-Pub 2020. PMID: 33898055.
9. Dono A, Zhu P, Zorofchian S, Takayasu T, Quezado MM, Rios A, Powers A, Esquenazi Y, Ballester LY. Variable expression of CXCR4 in molecular subtypes of infiltrating gliomas. Clin Neuropathol 40(2):98-107, 2021. PMID: 33300867.
10. Lopez-Rivera V, Dono A, Lewis CT, Chandra A, Abdelkhaleq R, Sheth SA, Ballester LY, Esquenazi Y. Extent of resection and survival outcomes of geriatric patients with glioblastoma: Is there benefit from aggressive surgery?. Clin Neurol Neurosurg 202:106474, 2021. e-Pub 2021. PMID: 33454497.
11. Patrizz A, Dono A, Zhu P, Tandon N, Ballester LY, Esquenazi Y. Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes?. J Neurooncol 152(1):163-172, 2021. e-Pub 2021. PMID: 33481149.
12. Dono A, Amsbaugh M, Martir M, Smilie RH, Riascos RF, Zhu JJ, Hsu S, Kim DH, Tandon N,Ballester LY, Blanco AI, Esquenazi Y. Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma. J Neurooncol 152(1):153-162, 2021. e-Pub 2021. PMID: 33492602.
13. Chandra A, Lopez-Rivera V, Dono A, Brandel MG, Lewis C, O'Connor KP, Sheth SA, Ballester LY, Aghi MK, Esquenazi Y. Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?. World Neurosurg 146:e755-e767, 2021. e-Pub 2020. PMID: 33171326.
14. Shah M, Takayasu T, Zorofchian Moghadamtousi S, Arevalo O, Chen M, Lan C, Duose D, Hu P, Zhu JJ, Roy-Chowdhuri S, Riascos RF, Chen H, Luthra R, Esquenazi Y, Ballester LY. Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies. J Mol Diagn 23(2):171-180, 2021. PMID: 33531134.
15. Dono A, Takayasu T, Yan Y, Bundrant BE, Arevalo O, Lopez-Garcia CA, Esquenazi Y, Ballester LY. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors. Neurosurgery 88(3):592-602, 2021. PMID: 33369669.
16. Dono A, Ramesh AV, Wang E, Shah M, Tandon N,Ballester LY, Esquenazi Y. The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastoma. Neurooncol Adv 3(1):vdab050, 2021. e-Pub 2021. PMID: 34131647.
17. Dono A, Ballester LY, Primdahl D, Esquenazi Y, Bhatia A. IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions. Curr Oncol Rep 23(2):20, 2021. e-Pub 2021. PMID: 33492489.
18. Lopez-Rivera V, Dono A, Abdelkhaleq R, Sheth SA, Chen PR, Chandra A, Ballester LY Esquenazi Y. Treatment trends and overall survival in patients with grade II/III ependymoma: The role of tumor grade and location. Clin Neurol Neurosurg 199:106282, 2020. e-Pub 2020. PMID: 33045626.
19. Dono A, Takayasu T, Ballester LY, Esquenazi Y. Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics. J Clin Neurosci 82(Pt A):1-8, 2020. e-Pub 2020. PMID: 33317715.
20. Patrizz A, Dono A, Zorofchian S, Hines G, Takayasu T, Husein N, Otani Y, Arevalo O, Choi HA, Savarraj J, Tandon N, Ganesh BP, Kaur B, McCullough LD, Ballester LY, Esquenazi Y. Glioma and temozolomide induced alterations in gut microbiome. Sci Rep 10(1):21002, 2020. e-Pub 2020. PMID: 33273497.
21. Takayasu T, Kurisu K, Esquenazi Y, Ballester LY. Ion Channels and Their Role in the Pathophysiology of Gliomas. Mol Cancer Ther 19(10):1959-1969, 2020. PMID: 33008831.
22. Li J, Zhao S, Lee M, Yin Y, Li J, Zhou Y, Ballester LY, Esquenazi Y, Dashwood RH, Davies PJA, Parsons DW, Li XN, Huang Y, Sun D. Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma. Sci Adv 6(42), 2020. e-Pub 2020. PMID: 33067228.
23. Dono A, Vu J, Anapolsky M, Hines G, Takayasu T, Yan Y, Tandon N, Zhu JJ, Bhattacharjee MB, Esquenazi Y, Ballester LY. Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses. J Neurooncol 149(3):463-472, 2020. e-Pub 2020. PMID: 33009979.
24. Zeineddine HA, Dono A, Kitagawa R, Savitz SI, Choi HA, Chang TR, Ballester LY, Esquenazi Y. Endoscopic Third Ventriculostomy for Hydrocephalus Secondary to Extraventricular Obstruction in Thalamic Hemorrhage: A Case Series. Oper Neurosurg (Hagerstown) 19(4):384-392, 2020. PMID: 32365205.
25. Takayasu T, Shah M, Dono A, Yan Y, Borkar R, Putluri N, Zhu JJ, Hama S, Yamasaki F, Tahara H, Sugiyama K, Kurisu K, Esquenazi Y, Ballester LY. Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors. Sci Rep 10(1):14326, 2020. e-Pub 2020. PMID: 32868820.
26. Lopez-Rivera V, Zhu P, Dono A, Lee S, Chen PR, Ballester LY, Sheth SA, Esquenazi Y. Increased Risk of Subsequent Meningioma Among Women with Malignant Breast Cancer. World Neurosurg 139:e271-e285, 2020. e-Pub 2020. PMID: 32298823.
27. Dienel A, Ammassam Veettil R, Hong SH, Matsumura K, Kumar T P, Yan Y, Blackburn SL, Ballester LY, Marrelli SP, McCullough LD, McBride DW. Microthrombi Correlates With Infarction and Delayed Neurological Deficits After Subarachnoid Hemorrhage in Mice. Stroke 51(7):2249-2254, 2020. e-Pub 2020. PMID: 32539672.
28. Dono A, Wang E, Lopez-Rivera V, Ramesh AV, Tandon N, Ballester LY, Esquenazi Y. Molecular characteristics and clinical features of multifocal glioblastoma. J Neurooncol 148(2):389-397, 2020. e-Pub 2020. PMID: 32440969.
29. Dono A, Patrizz A, McCormack RM, Putluri N, Ganesh BP, Kaur B, McCullough LD, Ballester LY, Esquenazi Y. Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters. CNS Oncol 9(2):CNS57, 2020. e-Pub 2020. PMID: 32602743.
30. Sandberg DI, Kharas N, Yu B, Janssen CF, Trimble A, Ballester LY, Patel R, Mohammad AS, Elmquist WF, Sirianni RW. High-dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a nonhuman primate model. J Neurosurg Pediatr:1-9. e-Pub 2020. PMID: 32357333.
31. Takayasu T, Esquenazi Y, Ballester LY. Plasma cfDNA in Glioblastoma-Letter. Clin Cancer Res 26(9):2275, 2020. PMID: 32358024.
32. Iqbal F, Ballester LY Aakash N, Sandberg DI, Bhattacharjee MB. 5-Year-Old Girl with Worsening Seizure Disorder. Brain Pathol 30(3):717-718, 2020. PMID: 32385958.
33. Ballester LY, Meis JM, Lazar AJ, Prabhu SS, Hoang KB, Leeds NE, Fuller GN. Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion. J Neuropathol Exp Neurol 79(3):347-351, 2020. PMID: 32016322.
34. Fischer GM, Vaziri Fard E, Shah MN, Patel RP, Von Allmen G, Ballester LY, Bhattacharjee MB. Filamin A-negative hyaline astrocytic inclusions in pediatric patients with intractable epilepsy: report of 2 cases. J Neurosurg Pediatr:1-7. e-Pub 2020. PMID: 32217802.
35. Mullarkey MP, Nehme G, Mohiuddin S, Ballester LY, Bhattacharjee MB, Trivedi D, Shah MN, Fuller GN, Zaky W, Sandberg DI. Posttreatment Maturation of Medulloblastoma into Gangliocytoma: Report of 2 Cases. Pediatr Neurosurg 55(4):222-231, 2020. e-Pub 2020. PMID: 32882694.
36. Dono A, Husein N, Ybarra C, Hasbun R, Choi HA, Ballester LY, Esquenazi Y. Real-time intracranial pressure monitoring during high-dose methotrexate treatment for primary central nervous system lymphoma. Cancer Treat Res Commun 25:100234, 2020. e-Pub 2020. PMID: 33161322.
37. Mejbel HA, Arudra SKC, Pradhan D, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Duose DY, Luthra R, Prieto VG, Ballester LY Aung PP. Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity. Cancers (Basel) 11(11), 2019. e-Pub 2019. PMID: 31684113.
38. Rajan A, Heery CR, Thomas A, Mammen AL, Perry S, O'Sullivan Coyne G, Guha U, Berman A, Szabo E, Madan RA, Ballester LY, Pittaluga S, Donahue RN, Tsai YT, Lepone LM, Chin K, Ginty F, Sood A, Hewitt SM, Schlom J, Hassan R, Gulley JL. Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma. J Immunother Cancer 7(1):269, 2019. e-Pub 2019. PMID: 31639039.
39. Zhu P, Du XL, Blanco AI, Ballester LY, Tandon N, Berger MS, Zhu JJ, Esquenazi Y. Impact of facility type and volume in low-grade glioma outcomes. J Neurosurg:1-11. e-Pub 2019. PMID: 31561219.
40. Morris SL, Zhu P, Rao M, Martir M, Zhu JJ, Hsu S, Ballester LY, Day AL, Tandon N, Kim DH, Shepard S, Blanco A, Esquenazi Y. Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent Glioblastoma. World Neurosurg 127:e523-e533, 2019. e-Pub 2019. PMID: 30954746.
41. Vantaku V, Dong J, Ambati CR, Perera D, Donepudi SR, Amara CS, Putluri V, Ravi SS, Robertson MJ, Piyarathna DWB, Villanueva M, von Rundstedt FC, Karanam B, Ballester LY, Terris MK, Bollag RJ, Lerner SP, Apolo AB, Villanueva H, Lee M, Sikora AG, Lotan Y, Sreekumar A, Coarfa C, Putluri N. Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer. Clin Cancer Res 25(12):3689-3701, 2019. e-Pub 2019. PMID: 30846479.
42. Ali FS, Arevalo O, Zorofchian S, Patrizz A, Riascos R, Tandon N, Blanco A, Ballester LY, Esquenazi Y. Cerebral Radiation Necrosis: Incidence, Pathogenesis, Diagnostic Challenges, and Future Opportunities. Curr Oncol Rep 21(8):66, 2019. e-Pub 2019. PMID: 31218455.
43. Esquenazi Y, Ballester LY. Telomerase reverse transcriptase alterations in human cancers: Diagnosis, prognosis, and therapeutic implications. Cancer Cytopathol 127(5):275-277, 2019. e-Pub 2019. PMID: 30958625.
44. Donaldson K, Buchanich JM, Grigson PS, Deneke E, Donaldson K, Vrana KE, Sacks DB, Kuehn GJ, Cardamone D, Pesce A, Smiley S, Nickley J, Krock K, Thomas R, Wilkerson ML, Farag HA, Challa SR, Tice AM, Wolk DM, Prichard J, Grant ML, Regmi S, Kerbacher B, Quinton LE, Farag HA, Tice AM, Wolk DM, Olson J, Haynes A, Yu E, McCully KS, Assi J, Wong M, Zarrin-Khameh N, Nifong TP, Hawker CD, Carlton GT, Rivera JM, Foulis PR, Zuraw A, Morlote D, Peker D, Reddy V, Harada S, Crutchfield C, Zander D, Barbhuiya MA, Pederson EC, Straub ML, Scott SC, Neibauer TL, Salter WF, Creer MH, Zhu Y, Bornhorst JA, Theobald JP, Algeciras-Schimnich A, Cao L, Knox J, Hardy R, Texas HJ, McGuire MF, Hunter RL, Brown RE, Hicks J, Hicks J, Cai Z, Brown RE, Ali Y, Cheng KC, Katz SR, Ding Y, Vanselow DJ, Yakovlev MA, Lin AY, Clark DP, Vargas P, Xin X, Copper JE, Canfield VA, Ang KC, Wang Y, Xiao X, De Carlo F, van Rossum DB, La Rivière PJ, Newell J, Hossler C, Roche M, Warrick J, Phaeton R, Kesterson J, Donaldson K, Myers C, Barrios R, Mintz P, Robyak K, Hamilton C, McGhee P, Pederson C, Straub M, Scott S, Neibauer T, Salter W, Creer M, Zhu Y, Hamilton C, Robyak K, McGhee P, Pederson C, Straub M, Scott S, Neibauer T, Salter W, Creer M, Zhu Y, Singh N, Morlote D, Vnencak-Jones C, Yemelyanova A, Harada S, Shah M, Moghadamtousi SZ, Lan C, Duose D, Hu P, Esquenazi Y, Luthra R, Ballester LY, Koenig AN, Liu CG, Zhang J, Kalia A, Al-Habib A, Van Arsdall M, Dhingra S, Patel K, Tatevian N. Abstracts of Presentations at the Association of Clinical Scientists 139th Meeting Hershey, PA, May 15-18, 2019. Ann Clin Lab Sci 49(3):403-416, 2019. PMID: 31308044.
45. Zorofchian S, Iqbal F, Rao M, Aung PP, Esquenazi Y, Ballester LY. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies. J Clin Pathol 72(4):271-280, 2019. e-Pub 2018. PMID: 30467241.
46. Ballester LY, Moghadamtousi SZ, Leeds NE, Huse JT, Fuller GN. Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases. Acta Neuropathol Commun 7(1):63, 2019. e-Pub 2019. PMID: 31036092.
47. Jour G, Vasudevaraja V, Prieto VG, Snuderl M, Torres-Cabala CA, Al-Rohil R, Sulman EP, Ballester LY, Aung PP. BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor. Mod Pathol 32(3):338-345, 2019. e-Pub 2018. PMID: 30310175.
48. Hong B, Muili K, Bolyard C, Russell L, Lee TJ, Banasavadi-Siddegowda Y, Yoo JY, Yan Y, Ballester LY, Bockhorst KH, Kaur B. Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema. Mol Ther Oncolytics 12:93-102, 2019. e-Pub 2018. PMID: 30719499.
49. Park AK, Kim P, Ballester LY, Esquenazi Y, Zhao Z. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma. Neuro Oncol 21(1):59-70, 2019. PMID: 30053126.
50. Arevalo OD, Soto C, Rabiei P, Kamali A, Ballester LY, Esquenazi Y, Zhu JJ, Riascos RF. Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse. Front Neurol 10:460, 2019. e-Pub 2019. PMID: 31133966.
51. Zorofchian S, El-Achi H, Yan Y, Esquenazi Y, Ballester LY. Characterization of genomic alterations in primary central nervous system lymphomas. J Neurooncol 140(3):509-517, 2018. e-Pub 2018. PMID: 30171453.
52. Ballester LY, Boghani Z, Baskin DS, Britz GW, Olsen R, Fuller GN, Powell SZ, Cykowski MD. Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins. Brain Pathol 28(6):1012-1019, 2018. e-Pub 2018. PMID: 29509313.
53. Ballester LY, Lu G, Zorofchian S, Vantaku V, Putluri V, Yan Y, Arevalo O, Zhu P, Riascos RF, Sreekumar A, Esquenazi Y, Putluri N, Zhu JJ. Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors. Acta Neuropathol Commun 6(1):85, 2018. e-Pub 2018. PMID: 30170631.
54. Ballester LY, Glitza Oliva IC, Douse DY, Chen MM, Lan C, Haydu LE, Huse JT, Roy-Chowdhuri S, Luthra R, Wistuba II, Davies MA. Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease. J Neuropathol Exp Neurol 77(7):628-635, 2018. PMID: 29873738.
55. Achi HE, Lally JE, Riascos RF, Zhu JJ, Tandon N, Esquenazi Y, Bhattacharjee MB, Ballester LY. Primary Central Nervous System Lymphoma with Associated Demyelination and Creutzfeldt Astrocytes. Ann Clin Lab Sci 48(4):534-537, 2018. PMID: 30143499.
56. Ali FS, Hussain MR, Gutiérrez C, Demireva P, Ballester LY, Zhu JJ, Blanco A, Esquenazi Y. Cognitive disability in adult patients with brain tumors. Cancer Treat Rev 65:33-40, 2018. e-Pub 2018. PMID: 29533821.
57. Ballester LY, Penas-Prado M, Leeds NE, Huse JT, Fuller GN. FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia. Cold Spring Harb Mol Case Stud 4(2), 2018. e-Pub 2018. PMID: 29610389.
58. Ballester LY, Cantu MD, Lim KPH, Sarabia SF, Ferguson LS, Renee Webb C, Allen CE, McClain KL, Mohila CA, Punia JN, Roy A, López-Terrada DH, John Hicks M, Fisher KE. The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis. Hematol Oncol 36(1):307-315, 2018. e-Pub 2017. PMID: 28219109.
59. Ballester LY, Dunbar E, Guha-Thakurta N, Henson JW, Chandler H, Watkins J, Fuller GN. Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted. Front Neurol 9:700, 2018. e-Pub 2018. PMID: 30210430.
60. Zorofchian S, Lu G, Zhu JJ, Duose DY, Windham J, Esquenazi Y, Ballester LY. Detection of the MYD88 p.L265P Mutation in the CSF of a Patient with Secondary Central Nervous System Lymphoma. Front Oncol 8:382, 2018. e-Pub 2018. PMID: 30294590.
61. Economides MP, Ballester LY Kumar VA, Jiang Y, Tarrand J, Prieto V, Torres HA, Kontoyiannis DP. Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often. J Infect 75(6):572-580, 2017. e-Pub 2017. PMID: 28919347.
62. Kim P, Ballester LY, Zhao Z. Domain retention in transcription factor fusion genes and its biological and clinical implications: a pan-cancer study. Oncotarget 8(66):110103-110117, 2017. e-Pub 2017. PMID: 29299133.
63. Ballester LY, Huse JT, Tang G, Fuller GN. Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results. Hum Pathol 69:15-22, 2017. e-Pub 2017. PMID: 28549927.
64. Boghani Z, Steele WJ, Cykowski MD, Ballester LY, Britz G. Creutzfeldt Cell Rich Glioblastoma: A Diagnostic Dilemma. Cureus 9(10):e1749, 2017. e-Pub 2017. PMID: 29226040.
65. Ballester LY, Fuller GN, Powell SZ, Sulman EP, Patel KP, Luthra R, Routbort MJ. Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors. J Neuropathol Exp Neurol 76(3):179-188, 2017. PMID: 28395087.
66. Lin FY, Bergstrom K, Person R, Bavle A, Ballester LY, Scollon S, Raesz-Martinez R, Jea A, Birchansky S, Wheeler DA, Berg SL, Chintagumpala MM, Adesina AM, Eng C, Roy A, Plon SE, Parsons DW. Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle. Cold Spring Harb Mol Case Stud 2(5):a001057, 2016. PMID: 27626068.
67. Ballester LY, Loghavi S, Kanagal-Shamanna R, Barkoh BA, Lin P, Medeiros LJ, Luthra R, Patel KP. Clinical Validation of a CXCR4 Mutation Screening Assay for Waldenstrom Macroglobulinemia. Clin Lymphoma Myeloma Leuk 16(7):395-403.e1, 2016. e-Pub 2016. PMID: 27268124.
68. Ballester LY, Sarabia SF, Sayeed H, Patel N, Baalwa J, Athanassaki I, Hernandez JA, Fang E, Quintanilla NM, Roy A, López-Terrada DH. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions. Pediatr Dev Pathol 19(2):94-100, 2016. e-Pub 2015. PMID: 26366474.
69. Ballester LY, Olar A, Roy-Chowdhuri S. Next-generation sequencing of central nervous systems tumors: the future of personalized patient management. Neuro Oncol 18(3):308-10, 2016. PMID: 26917589.
70. Ballester LY, Luthra R, Kanagal-Shamanna R, Singh RR. Advances in clinical next-generation sequencing: target enrichment and sequencing technologies. Expert Rev Mol Diagn 16(3):357-72, 2016. e-Pub 2016. PMID: 26680590.
71. Oyola-Cintrón J, Caballero-Rivera D, Ballester LY, Baéz-Pagán CA, Martínez HL, Vélez-Arroyo KP, Quesada O, Lasalde-Dominicci JA. Lateral diffusion, function, and expression of the slow channel congenital myasthenia syndrome αC418W nicotinic receptor mutation with changes in lipid raft components. J Biol Chem 290(44):26790-800, 2015. e-Pub 2015. PMID: 26354438.
72. Aung PP, Ballester LY, Goldberg LJ, Bhawan J. Incidental simultaneous finding of intravascular histiocytosis and reactive angioendotheliomatosis: a case report. Am J Dermatopathol 37(5):401-4, 2015. PMID: 25503604.
73. Ballester LY, Cowen EW, Lee CC. Adult T-cell leukemia-lymphoma associated with follicular mucinosis. Am J Dermatopathol 36(11):901-3, 2014. PMID: 24614206.
74. Yang AI, Khawaja AM, Ballester LY, Pack SD, Abdullaev Z, Patronas NJ, Inati SK, Theodore WH, Quezado MM, Zaghloul KA. Multifocal dysembryoplastic neuroepithelial tumours associated with refractory epilepsy. Epileptic Disord 16(3):328-32, 2014. PMID: 25204011.
75. Arnold MA, Ballester LY, Pack SD, Abdullaev Z, Merchant M, Tsokos MG. Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report. Pediatr Dev Pathol 17(4):302-7, 2014. e-Pub 2014. PMID: 24735198.
76. Aung PP, Ballester LY, Mahalingam M. Histopathology of Keratoacanthoma Revisited: Utility of Orificial Size as a Diagnostic Adjunct. Int J Surg Pathol 22(4):316-25, 2014. e-Pub 2013. PMID: 24284133.
77. Ahsan S, Raabe EH, Haffner MC, Vaghasia A, Warren KE, Quezado M, Ballester LY Nazarian J, Eberhart CG, Rodriguez FJ. Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma. Acta Neuropathol Commun 2:59, 2014. e-Pub 2014. PMID: 24894482.
78. Aung PP, Liu YC, Ballester LY, Robbins PF, Rosenberg SA, Lee CC. Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma. Hum Pathol 45(2):259-67, 2014. e-Pub 2013. PMID: 24290058.
79. Aung PP, Ballester LY, Abdullaev Z, Pack SD, Cummins DL, Mahalingam M. ER/PR positive epidermotropic primary cutaneous eccrine carcinoma as a cutaneous manifestation of MEN 2B. J Am Acad Dermatol 69(6):e310-2, 2013. PMID: 24238193.
80. Ballester LY, Wang Z, Shandilya S, Miettinen M, Burger PC, Eberhart CG, Rodriguez FJ, Raabe E, Nazarian J, Warren K, Quezado MM. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. Am J Surg Pathol 37(9):1357-64, 2013. PMID: 24076776.
81. Ballester LY, Capó-Vélez CM, García-Beltrán WF, Ramos FM, Vázquez-Rosa E, Ríos R, Mercado JR, Meléndez RI, Lasalde-Dominicci JA. Up-regulation of the neuronal nicotinic receptor α7 by HIV glycoprotein 120: potential implications for HIV-associated neurocognitive disorder. J Biol Chem 287(5):3079-86, 2012. e-Pub 2011. PMID: 22084248.
82. Ballester LY, Vanoye CG, George AL. Exaggerated Mg2+ inhibition of Kir2.1 as a consequence of reduced PIP2 sensitivity in Andersen syndrome. Channels (Austin) 1(3):209-17, 2007. e-Pub 2007. PMID: 18690034.
83. Ballester LY, Benson DW, Wong B, Law IH, Mathews KD, Vanoye CG, George AL. Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome. Hum Mutat 27(4):388, 2006. PMID: 16541386.
84. Lundquist AL, Turner CL, Ballester LY, George AL. Expression and transcriptional control of human KCNE genes. Genomics 87(1):119-28, 2006. e-Pub 2005. PMID: 16303284.
85. Chun TU, Epstein MR, Dick M, Andelfinger G, Ballester LY, Vanoye CG, George AL, Benson DW. Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm 1(2):235-41, 2004. PMID: 15851159.
86. Jeyakumar LH, Ballester LY Cheng DS, McIntyre JO, Chang P, Olivey HE, Rollins-Smith L, Barnett JV, Murray K, Xin HB, Fleischer S. FKBP binding characteristics of cardiac microsomes from diverse vertebrates. Biochem Biophys Res Commun 281(4):979-86, 2001. PMID: 11237759.

Abstracts

1. Dono A, Ramesh AV, Wang E, Shah M, Tandon N, Ballester LY, Esquenazi Y. The role of RB1 Alteration and 4q12 Amplification in IDH-WT Glioblastoma. American Association of Neurological Surgeons and Congress of Neurological Surgeons. 2021 Tumor Section Symposium, 2021.
2. Dono A, Ajami N, Ballester LY, Wargo JA, Esquenazi Y. TERT Immunohistochemistry Expression as a Surrogate of TERT Promoter Mutations in Infiltrating Gliomas. American Society of Clinical Pathologists. ASCP 2021 Annual Meeting, 2021.
3. Dono A, Ajami N, Ballester LY, Wargo JA, Esquenazi Y. Gut Microbiome Signatures Predict Outcomes in IDH-WT Glioblastoma. American Association of Neurological Surgeons and Congress of Neurological Surgeons. 2021 Tumor Section Symposium, 2021.
4. Dono A, Amsbaugh M, Martir M, Smilie RH, Riascos-Castaneda RF, Zhu JJ, Hsu S, Kim DH, Tandon N, Ballester LY, Blanco AI, Esquenazi Y. Genomic Alterations Predictive of Response to Radiosurgery in Recurrent IDH-WT Glioblastoma. Congress of Neurological Surgeons. 2021 CNS Annual meeting, 2021.
5. Arevalo O, De Alba L, Dono A, Takayasu T, Esquenazi Y, Ballester LY, Zhang X, Soto C, Zhu J, Riascos R. Prediction of BRAFV600E-Mutation Status Using Preoperative MR Imaging Phenotypes in Glioblastoma. ASNR 58th Annual Meeting, 2020.
6. Arevalo O, De Alba L, Dono A, Takayasu T, Esquenazi Y, Ballester LY, Zhang X, Soto C, Zhu J, Riascos R. Prediction of IDH1/2-Mutation Status in Preoperative MR Imaging Phenotypes in Glioblastoma using the VASARI feature set. ASNR 58th Annual Meeting, 2020.
7. De Alba L, Arevalo O, Dono A, Takayasu T, Esquenazi Y, Ballester LY, Zhang X, Soto C, Zhu J, Riascos R. . Prediction of pTERT-Mutation Status Using Preoperative MR Imaging Phenotypes in Glioblastoma. ASNR 58th Annual Meeting, 2020.
8. Dono A, Vu J, Anapolsky M, Hines G, Takayasu T, Tandon N, Bhattacharjee MB, Esquenazi Y, Ballester LY. Additional Genetic Alterations Improve the Classification of BRAF-mutant gliomas. American Association of Neuropathologist 96th Annual Meeting, 2020.
9. Achi HE, Dono A, Zhu P, Bundrant BE, Esquenazi Y, Ballester LY. Diffuse gliomas with FGFR alterations, histopathological features, genetic alterations, and potential clinical implications. American Association of Neuropathologist 96th Annual Meeting, 2020.
10. Arevalo O, De Alba L, Dono A, Takayasu T, Esquenazi Y, Ballester L, Zhang X, Soto C, Zhu J, and Riascos R. Prediction of BRAF V600E-Mutation Status Using Preoperative MR Imaging Phenotypes in Glioblastoma. American Society of Neuroradiology 58th Annual Meeting, 2020.
11. De Alba L, Arevalo O, Dono A, Takayasu T, Esquenazi Y, Ballester LY, Zhang X, Soto C, Zhu J, and Riascos R. Prediction of pTERT-Mutation Status Using Preoperative MR Imaging Phenotypes in Glioblastoma. American Society of Neuroradiology 58th Annual Meeting, 2020.
12. Arevalo O, De Alba L, Dono A, Takayasu T, Esquenazi Y, Ballester LY, Zhang X, Soto C, Zhu J, and Riascos R. Prediction of IDH1/2-Mutation Status in Preoperative MR Imaging Phenotypes in Glioblastoma using the VASARI feature set. American Society of Neuroradiology 58th Annual Meeting, 2020.
13. Zeineddine HA, Dono A, Kitagawa R, Savitz SI, Choi HA, Chang T, Ballester LY, and Esquenazi Y. Endoscopic Third Ventriculostomy for Hydrocephalus Secondary to Extra-Ventricular Obstruction in Thalamic Hemorrhage. American Association of Neurological Surgeons World of Neurosurgery meeting, 2020.
14. Dono A, Lopez-Rivera V, Sheth SA, Ballester LY, Esquenazi Y. Is there Benefit from Radiotherapy After Non-Gross Tumor Resection of Pleomorphic Xanthoastrocytoma?. American Association of Neurological Surgeons World of Neurosurgery meeting, 2020.
15. Takayasu T, Arevalo-Espejo O, Zhu P, Dono A, Tandon N, Ballester LY, Esquenazi Y. Extent of Resection Thresholds in Molecular Subgroups of IDH-wildtype glioblastoma. American Association of Neurological Surgeons World of Neurosurgery meeting, 2020.
16. Takayasu T, Shah M, Yan Y, Zorofchian S, Dono A, Putluri N, Zhu JJ, Yamasaki FA, Sugiyama, Kurisu K, Esquenazi Y, Ballester LY. Analysis of Cerebrospinal Fluid Circulating Tumor DNA and Metabolites in Patients with Central Nervous System Germ Cell Tumors. American Association of Neurological Surgeons World of Neurosurgery meeting, 2020.
17. Lopez-Garcia CA, Dono A, Takayasu T, Esquenazi Y, Ballester LY. PIK3CA Mutations Identify a Subset of Oligodendrogliomas with Poor Prognosis. United States and Canadian Academy of Pathology 109th Annual Meeting, 2020.
18. Dono A, Patrizz A, McCormack RM, Putluri N, Ganesh BP, Kaur B, McCullough LD, Ballester LY, Esquenazi Y. Glioma Induced Alterations in Fecal Short-Chain Fatty Acids and Neurotransmitters. 2020 American Association of Neurosurgeon / Congress of Neurological Surgeons Tumor Section Satellite Meeting, 2020.
19. Dono A, Wang E, Lopez-Rivera V, Ramesh AV, Tandon N, <b>Ballester LY</b>, and Esquenazi Y. Molecular Characteristics and Clinical Features of Multifocal Glioblastoma. 2020 American Association of Neurosurgeon / Congress of Neurological Surgeons Tumor Section Satellite Meeting, 2020.
20. Lopez-Garcia CA, Lopez-Rivera V, Dono A, Ballester LY, Esquenazi Y. The relationship of hormone exposure in breast cancer and subsequent risk of high-grade gliomas. 2020 Society of Neuro-Oncology Annual Scientific Meeting, 2020.
21. Dono A, Zhu P, Holmes E, Takayasu T, Blanco AI, Hsu S, Bhattacharjee MB, Zhu JJ, Ballester LY, Esquenazi Y, Tandon N. Reoperation in Molecular Subtypes of Recurrent Glioblastoma. 2020 Society of Neuro-Oncology Annual Scientific Meeting, 2020.
22. Dono A, Mitra S, Takayasu T, Zhu JJ, Tandon N, Esquenazi Y, Ballester LY. PTEN Mutations Predict Benefit from Tumor-Treating Fields Therapy in Patients with Recurrent Glioblastoma. 2020 Society of Neuro-Oncology Annual Scientific Meeting, 2020.
23. Dono A, Alfaro-Munoz K, Yan Y, Lopez-Garcia CA, Soomro Z, Williford G, Takayasu T, Robell L, Majd N, de Groot J, Esquenazi Y, Kamiya-Matsouka C, Ballester LY. Molecular, Histologic and Clinical Characteristics of Oligodendrogliomas: A Multi-institutional Retrospective Study. 2020 Society of Neuro-Oncology Annual Scientific Meeting, 2020.
24. Shah M, Zorofchian S, Lan C, Duose D, Hu P, Esquenazi Y, Luthra R, Ballester LY. Detecting Mutations in Cerebrospinal fluid: Liquid Biopsy for Diagnosis of Central Nervous System Metastases. 10th Annual meeting of the Cancer Genome Consortium, 2019.
25. Shah M, Zorofchian S, Lan C, Duose D, Hu P, Esquenazi Y, Luthra T, Ballester LY. Detecting Mutations in Cerebrospinal fluid: Liquid Biopsy for Diagnosis of Central Nervous System Metastases. 139th Annual meeting of the Association of Clinical, 2019.
26. Ballester LY. The increasingly important role of molecular diagnostics in neuropathology. Department of Pathology Grand Rounds, 2019.
27. Ballester, LY, Moghadamtousi, SZ, Leeds, NE, Huse, JT, Fuller, GN. Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases. 2019 AANP meeting, 2019.
28. Dono A, Yan A, Hines G, Esquenazi Y, Ballester LY. Analysis of Genomic Alterations in 144 Brain Metastases. 2019 SNO Inaugural Brain Metastases Meeting, 2019.
29. Ballester LY. The increasingly important role of molecular diagnostics in neuropathology. 2018 Department of Pathology Grand Rounds, 2018.
30. Ballester LY, Gurangong L, Vantaku V, Zorofchian S, Putluri V, Yan Y, Arevalo-Espejo O, Riascos RF, Sreekumar A, Esquenazi Y, Putluri N, Zhu JJ. Metabolomic Analysis of CSF Differentiates Primary and Metastatic CNS Tumors from Non-Neoplastic Disease. AANP meeting, 2018.
31. Belousova T, Jaitly V, Arevalo-Espejo O, Riascos RF, Liu J, Esquenazi Y, Bhattacharjee M, Ballester LY. CSF cytology in the evaluation of primary and metastatic CNS malignancies. AANP meeting, 2018.
32. Vaziri-Fard E, Shah MN, von Allmen G, Patel RJ, Ballester LY, Bhattacharjee M. Eosinophilic Cytoplasmic Astrocytic Inclusions in Pediatric Patients with Epilepsy: A Report of 2 Cases. 2018 AANP meeting, 2018.
33. Zorofchian S, Guangrong L, Zhu JJ, Esquenazi Y,Ballester LY. 2018 AANP meeting. Detection of the MYD88 p.L265P mutation in the CSF of a Patient with Central Nervous System Lymphoma, 2018.
34. Ballester LY, Glitza Oliva IC, Douse DY, Chen MM, Lan C, Haydu LE, Huse JT, Roy-Chowdhuri S, Luthra R, Wistuba II, Davies MA. Evaluating Circulating Tumor DNA from the Cerebrospinal Fluid of Patients with Melanoma and Leptomeningeal Disease. 2018 AANP meeting, 2018.
35. Ballester LY. Evaluating Circulating Tumor DNA from Cerebrospinal Fluid. MD Anderson Cancer Center, Brain Tumor Center Research Retreat, 2017.
36. Ballester LY. Evaluating Circulating Tumor DNA from Cerebrospinal Fluid. 2017 MD Anderson Global Academic Programs Annual Conference, 2017.
37. Ballester LY. Evaluating Circulating Tumor DNA from Cerebrospinal Fluid. Cancer Genomics Consortium Summer Meeting, 2017.
38. Ballester LYb, Douse DY, Lan C, Haydu LE, Huse JT, Roy-Chowdhuri S, Luthra R, Glitza-Oliva IC, Wistuba II, Davies MA. Evaluating Circulating Tumor DNA from Cerebrospinal Fluid. 2017 MD Anderson Cancer Center, Brain Tumor Center Research Retreat, 2017.
39. Ballester LY, Fuller GN, Powell SZ, Sulman EP, Patel KP, Luthra R, Routbort MJ. Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors. 2017 USCAP meeting, 2017.
40. Ballester LY, Sarabia SF, Sayeed S, Patel N, Baalwa J, Fang E, Quintanilla N, Roy A, Lopez-Terrada D. Molecular Characterization of Pediatric Thyroid Carcinomas. 2015 TSP meeting, 2015.
41. Ballester LY, Wang Z, Miettinen M, Rodriguez F, Raabe E, Nazarian J, Eberhart C, Warren K, Quezado M. Overexpression of the Chromatin Remodeling Proteins ARID1A, BRG1 and SMARCD3 in Adult and Pediatric Gliomas. 2015 USCAP meeting, 2015.
42. Ballester LY, Loghavi S, Kanagal-Shamanna R, Barkoh BA, Lin P, Medeiros LJ, Luthra R, Patel KP. Clinical Validation of a CXCR4 Mutation Screening Assay for Waldenstrom Macroglobulinemia. 2015 AMP meeting, 2015.
43. Ballester LY, Sarabia SF, Allen CE, Webb CR, Roy A, López-Terrada DH, McClain KL, Hicks MJ, Fisher KE. . BRAF p.V600E Analysis in Pediatric Langerhans Cell Histiocytosis: Is There a Role for Immunohistochemistry. 2015 AMP meeting, 2015.
44. Ballester LY, Ellezam B, Adesina AM. Chronic active HSV encephalitis in a patient with a negative HSV test from the CSF. 2014 AMP meeting, 2014.
45. Ballester LY. Clinical Cases from the NIH Clinical Center: Allogeneic Hematopoietic Stem Cell Transplant for Dock8 Deficiency: Past, Present and Future. NIH/NCI, Clinicopathologic Grand Rounds, 2014.
46. Ballester LY, Aung PP, Lara-Otero K, Linehan WM, Merino MJ. Do Cutaneous Leiomyomas have similar morphological and molecular alterations to uterine tumors in the Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome (HLRCC)?. 2013 USCAP meeting, 2013.
47. Ballester LY, Wang Z, Shandylia S, Miettinen M, Burger P, Eberhart C, Rodriguez F, Raabe E, Warren K, Quezado M. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic brainstem gliomas. 2013 USCAP meeting, 2013.
48. Ballester LY, Aung PP, Walter BA, Garcia-Macias C, Merino MJ. Overexpression of HER2/neu can be determined by a new HistoSonda® probe. A comparison with traditional methods FISH, CISH, and IHC in urothelial carcinoma (UC). ASCP annual meeting, 2012.
49. Aung PP, Lai J, Ballester LY, DiGiovanna JJ, Linehan M, Lee CR, Stern JB, Pinto PA. An Unusual Presentation of Glomeruloid Hemangioma in a Patient with VHL Syndrome: A Case Report and Review of Literature. International Society of Dermatopathology, 2012.
50. Shandilya S, Ballester LY, Wang Z, Miettinen M, Burger P, Eberhart C, Rodriguez F, Raabe E, Quezado M, and Warren K.. An Immunohistochemical Profile of Protein Expression in Pediatric Diffuse Intrinsic Pontine Gliomas. NIH Summer Research Program Poster Day, 2012.
51. Ballester LY, Aung PP, Siddiqui S, Stetler-Stevenson M, Kreitman RJ, Roth M, Filie AC. Relapsed Hairy Cell Leukemia (HCL): Cytological and Immunophenotypical Findings of an Unusual Presentation in Pleural Effusion. 2012 ASCP annual meeting, 2012.
52. Ballester LY, García-Beltran W, Ramos FM, Vazquez E, Capo C, Ríos R, Mercado JR, Acevedo L, Lasalde-Dominicci JA.. HIV-gp120 Induces Up-regulation of the alpha-7-nAChR; Implications for HIV Associated Dementia. The 8th Conference for Specialized Neuroscience Research Programs, 2010.
53. Ballester LY, Capo-Velez CM, Garcia-Beltran WF, Ramos FM, Vazquez-Rosa E, Rios R, Mercado JR, Melendez RI, Lasalde-Dominicci JA. Up-regulation of the Neuronal Nicotinc Receptor alpha-7 by HIV-GP120 Potential Implications for HIV Associated Neurocognitive Disorder. Conference of the Specialized Neuroscience Research Program, 2010.
54. Ballester LY, Benson DW, Wong B., Law IH, Mathews KD, Vanoye CG, George AL. Trafficking-competent and Trafficking-defective KCNJ2 Mutations Associated with Andersen Syndrome. NHLBI cardiovascular diversity research supplement awardee session, 2005.
55. Ballester LY, Benson DW, Vanoye CG, George AL, Jr. Characterization of Kir2.1 mutations associated with Andersen syndrome. Biophysical Journal, 2003.

Book Chapters

1. Fuller GN, Ballester LY. Central Nervous System Section. Brain, spinal cord and meninges. In: Sternberg's Diagnostic Surgical Pathology. 7th, 2022.
2. Huse J, Ballester LY. Pathology and Molecular Genetics of Brain Tumors. In: Bradley's Neurology in Clinical Practice. 8th, 2021.
3. Fuller GN, Ballester LY, Burger PC. Central Nervous System. In: Histology for Pathologists. Lippincot Williams and Wilkins, 2019.
4. Ballester LY, Fuller G.N., Goodman C.J. The Central Nervous System. In: Rubin's Pathology: Clinicopathologic Foundations of Medicine. 8th, 2019.
5. Fuller GN, Ballester LY, Perry A,. Epithelial, Neuroendocrine and Metastatic Lesions. In: Practical Surgical Neuropathology. Elsevier: San Diego, CA, 2018.
6. Ballester LY, Fuller GN. Intraoperative Consultation and Optimal Processing. In: Practical Surgical Neuropathology. Elsevier: San Diego, CA, 2018.
7. Ballester LY, Aung PP, Lee CR. MAPK Pathway in Melanoma. In: Genetics of Melanoma. Springer Publishing: New York, 2016.